Cargando…
Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report
Advanced uterine leiomyosarcoma (LMS) is a rare and extremely aggressive disease. In patients with advanced and unresected uterine LMS, multidisciplinary therapy is the best treatment option, although no consensus exists on the efficacy of the treatment. The present study describes the case of a 41-...
Autores principales: | SHIRAFUJI, AYA, SHINAGAWA, AKIKO, KUROKAWA, TETSUJI, YOSHIDA, YOSHIO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081420/ https://www.ncbi.nlm.nih.gov/pubmed/25009648 http://dx.doi.org/10.3892/ol.2014.2193 |
Ejemplares similares
-
Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
por: Inoue, Daisuke, et al.
Publicado: (2015) -
Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection
por: Onuma, Toshimichi, et al.
Publicado: (2020) -
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
por: Tsuyoshi, Hideaki, et al.
Publicado: (2018) -
(18)F-FDG/(18)F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
por: Yamamoto, Makoto, et al.
Publicado: (2017) -
Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma
por: Wong, Philip, et al.
Publicado: (2013)